(Q80342340)
Statements
Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions (English)
Coskun U
Bukan N
Sancak B
Günel N
Ozenirler S
Unal A
1 January 2004